AU7712598A - Lipid-reduced oral formulation for egg yolk-derived therapeutic protein - Google Patents

Lipid-reduced oral formulation for egg yolk-derived therapeutic protein

Info

Publication number
AU7712598A
AU7712598A AU77125/98A AU7712598A AU7712598A AU 7712598 A AU7712598 A AU 7712598A AU 77125/98 A AU77125/98 A AU 77125/98A AU 7712598 A AU7712598 A AU 7712598A AU 7712598 A AU7712598 A AU 7712598A
Authority
AU
Australia
Prior art keywords
lipid
egg yolk
therapeutic protein
oral formulation
derived therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77125/98A
Inventor
Vitaliano Cama
Charles R. Sterling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arizona Board of Regents of University of Arizona
Original Assignee
Arizona Board of Regents of University of Arizona
University of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona Board of Regents of University of Arizona, University of Arizona filed Critical Arizona Board of Regents of University of Arizona
Publication of AU7712598A publication Critical patent/AU7712598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU77125/98A 1997-06-04 1998-06-03 Lipid-reduced oral formulation for egg yolk-derived therapeutic protein Abandoned AU7712598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4851797P 1997-06-04 1997-06-04
US60048517 1997-06-04
PCT/US1998/011142 WO1998055143A1 (en) 1997-06-04 1998-06-03 Lipid-reduced oral formulation for egg yolk-derived therapeutic protein

Publications (1)

Publication Number Publication Date
AU7712598A true AU7712598A (en) 1998-12-21

Family

ID=21955005

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77125/98A Abandoned AU7712598A (en) 1997-06-04 1998-06-03 Lipid-reduced oral formulation for egg yolk-derived therapeutic protein

Country Status (2)

Country Link
AU (1) AU7712598A (en)
WO (1) WO1998055143A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005005481A2 (en) * 2003-07-10 2005-01-20 Avitek Pharma Inc. Combination therapy for gastroenteric diseases caused by microorganisms
US20070275036A1 (en) 2006-05-18 2007-11-29 Celldyne Biopharma, Llc Avian follistatin product
US10835576B2 (en) 2006-05-18 2020-11-17 Myos Rens Technology Inc. Method of obtaining effective amounts of avian follistatin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A

Also Published As

Publication number Publication date
WO1998055143A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
EG23685A (en) Activated protein c formulations
AU6030398A (en) Human proteins
AU5721798A (en) Human mage-like protein
AU4770596A (en) Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products
AU6518399A (en) Human ankyrin family protein
AU7964398A (en) Dental formulation
AU2205499A (en) Human regulatory proteins
IL114673A0 (en) Pharmaceutical compositions containing protein
AU4480697A (en) Human nm23-like protein
AU7954298A (en) Human protein phosphatase ii-c-like protein
AU9017598A (en) Human frezzled-like protein
AU5148098A (en) Human eosinophil-derived basic protein
AU6056898A (en) Human lea-motif developmental protein
AU7368898A (en) Human translocation associated protein
AU7712598A (en) Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
AU7135398A (en) Human rho protein
AU3983899A (en) Human promonocyte associated protein: prmnc
AU4849299A (en) Human emr1-like g protein coupled receptor
AU7572398A (en) New human transmembrane protein
AU4744997A (en) Novel human phospholemman-like protein
AU4582597A (en) Therapeutic proteins
AU6050198A (en) Novel human cystatin-like protein
AU2101799A (en) Human vps35/mem3-related protein
AU4992099A (en) Human presenilin-associated protein
AU2593199A (en) Human smn-like protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase